Hutchmed
Clinical trials sponsored by Hutchmed, explained in plain language.
-
New drug trial tests hope for Hard-to-Treat tumors
Disease control CompletedThis study tested a drug called surufatinib in Japanese patients with advanced neuroendocrine tumors that had stopped responding to standard treatments. The first part checked the drug's safety and the best dose, while the second part measured how well it shrank tumors. A total o…
Phase: PHASE1, PHASE2 • Sponsor: Hutchmed • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Scientists test if breakfast changes how your body handles a pill
Knowledge-focused CompletedThis early-stage study aimed to understand how eating food, especially high-fat or low-fat meals, affects how the body absorbs and processes a new drug called HMPL-523. It involved 18 healthy Chinese volunteers who took the drug under different fasting and fed conditions. The mai…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Knowledge-focused
Last updated Apr 02, 2026 02:11 UTC
-
Drug maker tests if new pill formula works the same as the old one
Knowledge-focused CompletedThis study tested whether a new, modified version of a drug tablet (HMPL-523) is absorbed by the body in the same way as the original version. It involved 54 healthy Chinese volunteers who took both tablet versions in a specific order. The main goal was to see if the two versions…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC